Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer

Henry Rodriguez-Broadbent, Philip J. Law, Amit Sud, Kimmo Palin, Sari Tuupanen, Alexandra Gylfe, Ulrika A. Hanninen, Tatiana Cajuso, Tomas Tanskanen, Johanna Kondelin, Eevi Kaasinen, Antti-Pekka Sarin, Samuli Ripatti, Johan G. Eriksson, Harri Rissanen, Paul Knekt, Eero Pukkala, Pekka Jousilahti, Veikko Salomaa, Aarno PalotieLaura Renkonen-Sinisalo, Anna Lepisto, Jan Bohm, Jukka-Pekka Mecklin, Nada A. Al-Tassan, Claire Palles, Lynn Martin, Ella Barclay, Susan M. Farrington, Maria N. Timofeeva, Brian F. Meyer, Salma M. Wakil, Harry Campbell, Christopher G. Smith, Shelley Idziaszczyk, Timothy S. Maughan, Richard Kaplan, Rachel Kerr, David Kerr, Michael N. Passarelli, Jane C. Figueiredo, Daniel D. Buchanan, Aung K. Win, John L. Hopper, Mark A. Jenkins, Noralane M. Lindor, Polly A. Newcomb, Steven Gallinger, David Conti, Fred Schumacher, Graham Casey, Lauri A. Aaltonen, Jeremy P. Cheadle, Ian P. Tomlinson, Malcolm G. Dunlop, Richard S. Houlston

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalInternational Journal of Cancer
Volume140
Issue number12
Pages (from-to)2701-2708
Number of pages8
ISSN0020-7136
DOIs
Publication statusPublished - 15 Jun 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Mendelian randomisation
  • hyperlipidaemia
  • cholesterol
  • colorectal cancer
  • risk
  • GENOME-WIDE METAANALYSIS
  • BLOOD-LIPIDS
  • DISEASE
  • IDENTIFICATION
  • REGRESSION
  • TRAITS
  • LOCI
  • 3122 Cancers
  • 3126 Surgery, anesthesiology, intensive care, radiology

Cite this